JPMorgan’s top biopharma picks for 2025
JPMorgan has an updated set of biopharma names that could see upside this year, after a hot and cold period for some companies in the...
Tag : JPMorgans
JPMorgan’s JEPI can profit from volatility in 2025 — and it yields 7%
With investors expecting a volatile market in 2025, many are turning to options strategies to help smooth the ride — and produce income. Stocks have...
JPMorgan’s top short ideas for 2025
Stocks such as Novavax and Airbnb are among several JPMorgan says to sell short heading into the new year. Major stock market averages have had...